<p>Proliferation of PC-3 cells treated with increasing dosage (0, 5, 10, 20 µM) of CAPE in combination with increasing concentration of etoposide (A), paclitaxol (B), vinblastine (C), mitoxantrone (D), and estramustine (E) for 72 h was determined by 96-well proliferation assay. The right part of the figure show the ratio of expected cell number/observed cell number. For example, treatment of 5 µM of CAPE or 1 nM vinblastine decreases cell number of PC-3 to 80.9% and 88.7%, respectively, compared to the control (no treatment). The expected cell number of treatment combining 5 µM of CAPE and 1 nM vinblastine is 0.809*0.887 = 71.8%. The observed cell number is 48.8% compared to the control. So the ratio is 0.718/0.488 = 1.5. Ratio larger than ...
<p>Combination index (CI) graphs, generated in Calcusyn, of EPZ-6438 with Mafosfamide, Doxorubicin, ...
<p>Growth inhibition assay performed on HUVEC and EPC after 72-h incubation of a conventional regime...
<p>MTT assay was performed to evaluate A2780 and A2780 cell lines proliferation in response to 10 µM...
<p>Proliferation of PC-3 cell treated with increasing concentration of CAPE was determined by Trypan...
<p>(A) PC-3 cells transfected with a 4X NF-κB luciferase reporter plasmid for 24 hr were treated wit...
<p><b>A</b>. (a) Cell viability analysis according to treatment with simvastatin (10 μM) and <i>NF-κ...
<p>(<b>A</b>) Three human leukemia cell lines were screened against the LOPAC1280 compound library w...
<p>Protein abundance or activity being stimulated by CAPE treatment are labeled with red upward arro...
<p>LNCaP 104-S, 104-R1, 104-R2, PC-3, and DU-145 cells were treated with increasing concentrations o...
Using the primary cultured cells of cancerous thoracic fluid, cancerous ascites and mammary cancer t...
<p>(A) Effects of halofantrine and vinblastine on MDA-MB-231 TNBC cell proliferation. IC<sub>50</sub...
Combinatory drug treatment, e.g. targeting different proteins in specific signaling pathways tailore...
<p>(A–B) Human CRC cells were treated with either CAPE or CAPPE (at concentrations of 0, 5, 10, 20, ...
<p>After 72h of continuous exposure to drugs (either trastuzumab or fulvestrant as single agents) hi...
<p>Protein levels of wild type PC-3, PC-3 cells transfect with scramble control (20 nM), and PC-3 ce...
<p>Combination index (CI) graphs, generated in Calcusyn, of EPZ-6438 with Mafosfamide, Doxorubicin, ...
<p>Growth inhibition assay performed on HUVEC and EPC after 72-h incubation of a conventional regime...
<p>MTT assay was performed to evaluate A2780 and A2780 cell lines proliferation in response to 10 µM...
<p>Proliferation of PC-3 cell treated with increasing concentration of CAPE was determined by Trypan...
<p>(A) PC-3 cells transfected with a 4X NF-κB luciferase reporter plasmid for 24 hr were treated wit...
<p><b>A</b>. (a) Cell viability analysis according to treatment with simvastatin (10 μM) and <i>NF-κ...
<p>(<b>A</b>) Three human leukemia cell lines were screened against the LOPAC1280 compound library w...
<p>Protein abundance or activity being stimulated by CAPE treatment are labeled with red upward arro...
<p>LNCaP 104-S, 104-R1, 104-R2, PC-3, and DU-145 cells were treated with increasing concentrations o...
Using the primary cultured cells of cancerous thoracic fluid, cancerous ascites and mammary cancer t...
<p>(A) Effects of halofantrine and vinblastine on MDA-MB-231 TNBC cell proliferation. IC<sub>50</sub...
Combinatory drug treatment, e.g. targeting different proteins in specific signaling pathways tailore...
<p>(A–B) Human CRC cells were treated with either CAPE or CAPPE (at concentrations of 0, 5, 10, 20, ...
<p>After 72h of continuous exposure to drugs (either trastuzumab or fulvestrant as single agents) hi...
<p>Protein levels of wild type PC-3, PC-3 cells transfect with scramble control (20 nM), and PC-3 ce...
<p>Combination index (CI) graphs, generated in Calcusyn, of EPZ-6438 with Mafosfamide, Doxorubicin, ...
<p>Growth inhibition assay performed on HUVEC and EPC after 72-h incubation of a conventional regime...
<p>MTT assay was performed to evaluate A2780 and A2780 cell lines proliferation in response to 10 µM...